可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Garza L, Aude YW, Saucedo JF. Can we preventin-stent restenosis? [J] . Curr Opin Cardiol, 2002, 17(5):518-525.
[2] Schwartz RS, Henry TD. Pathophysiology of coronary artery restenosis [J] . Rev Cardiovasc Med, 2002, 3(Suppl5):S4-S9.
[3] 田建伟, 赵连友, 郑强荪. PTCA术后再狭窄机制的研究现状 [J] . 心脏杂志, 2003, 14(4):353-358.
[4] 高东升, 陈润芳. 冠状动脉内照射对再狭窄的防治作用及其存在的问题 [J] . 心脏杂志, 2002, 14(5):443-445.
[5] Glover C, Ma X, Chen YX, et al.Humanin-stent restenosis tissue obtained by means of coronary atherectomy consists of an abundant proteogly can matrix with a paucity of cell proliferation [J] . Am Heart J, 2002, 144(4):702-709.
[6] ribichini F, Wijns W, Ferrero V, et al. Effect of angiotensin-converting enzyme inhibition on restenosis after coronary stenting [J] . Am J Cardiol, 2003, 91(2):154-158.
[7] Palmaz JC, Bailey S, Marton D, et al. Influence of stent design and material composition on procedure outcome [J] . J Vasc Surg, 2002, 14(12):1031-1039.
[8] Orford JL, Fasseas P, Denktas AE, et al. Safety and efficacy of cutting balloon angioplasty: the may oclinic experience [J] . J Invasive Cardiol, 2002, 14(12):725-727.
[9] Radke PW, Blindt R, Haager PK, et al. Rotational atherectomy for the treatment of in-stent restenosis [J] . Minerva Cardioangiol, 2002, 50(5):555-563.
[10] Fattori R, Piva T. Drug-eluting stents in vascular intervention [J] . Lancet, 2003, 361(9353):247-249.
[11] New G, Moses JW, Roubin GS, et al. Estrogen-eluting, phosphorylcholine-coated stent implantation is associated with reduced neointimal formation but no delay invascular repair in a porcine coronary model [J] . Catheter Cardiovasc Interv, 2002,57(2):266-271.